Strategic Advisors

The rEVO Biologics strategic advisors are committed to ensuring that the company carries out its mission in developing and commercializing breakthrough treatments and making a real difference in the lives of patients.

James A. Geraghty

James Geraghty is currently an Entrepreneur in Residence at Third Rock Ventures in Boston and Chairman of Idera Pharmaceuticals (NASDAQ: IDRA). Prior to Third Rock Ventures, Mr. Geraghty served as Senior Vice President, North America strategy and business development, at Sanofi. Before Sanofi, he spent 20 years at Genzyme Corporation, most recently as Senior Vice President and an Officer. While at Genzyme, his roles included, President of Genzyme Europe and General Manager of Genzyme's cardiovascular business. He also led strategic transactions that brought important new products into Genzyme. He served as a director of GTC Biotherapeutics (formerly Genzyme Transgenics Corporation), where he was Chairman, President and CEO. Mr. Geraghty also oversaw Genzyme's Humanitarian Assistance for Neglected Diseases program, under which Genzyme helped develop innovative therapeutic programs on a non-commercial basis. He served as co-chair of the executive committee for BIO 2007. A graduate of the Yale Law School, he has published articles in the Yale Law Journal, Health Affairs, and other publications. Mr. Geraghty holds an MS from the University of Pennsylvania and a BA from Georgetown University.

Christian Béchon

Christian Béchon brings more than two decades of business experience to his role at LFB. He is a graduate of the Ecole Centrale des Arts et Manufactures engineering school, Institut d'Etudes Politiques de Paris, he became a public auditor on leaving the Ecole Nationale d'Administration in 1988. Before joining LFB, he held the following positions: Deputy General Secretary of the public auditing body for French Social Security from 1988 to 1992, then General Secretary of IPSN, the French Nuclear Protection and Safety Institute from 1992 to 1994. From April 1994 to May 1995, he was Deputy Chief of Staff to André Rossinot, then Minister for Public Service under Prime Minister Edouard Balladur. After a short spell as General Secretary of CNES, the National Space Research Centre (May-June 1995), he was Chief of Staff to Elisabeth Hubert, Minister for Public Health and Health Insurance under Prime Minister Alain Juppé from June to November 1995. He was then an investigator on the Central Investigative Committee on the cost and yield of public services (1996) before returning to public auditing in April 1997. At the same time, he was General Delegate to the Industrial Forum Circle from 2000 to 2002. From 2000 to 2004, he has been Deputy Chief of Staff to Francis Mer at the Ministry of the Economy, Finance and Industry under Prime Minister Jean-Pierre Raffarin from 2002 to 2004, as well as Chief of Staff to Industry Minister Nicole Fontaine. Senior Advisor for the Boston Consulting Group in 2005, Christian Béchon was appointed Chairman and Chief Executive Officer of LFB S.A. in 2006.

Pamela W. McNamara

Since 2011, Ms. McNamara has served as a co-founder of Health Helm, Inc. and an advisor on the faculty of the Hult International Business School and a consultant for the Center for Innovation, Excellence and Learning. From 2009 to 2011, Ms. McNamara served as the president of Cambridge Consultants, Inc.

Ms. McNamara served as the chief executive officer of CRF, Inc. from 2003 to 2008. Ms. McNamara served as chief executive officer of Arthur D. Little, Inc. from 2001 to February 2002, and as managing director of Arthur D. Little from 1997 to 2001, and as a partner of Arthur D. Little since 1992.

Ms. McNamara served the board of GTC Biotherapeutics, Inc. from 2002 to 2010. She currently serves as a member of the board of SouthCoast Health System and Hospitals Group, on the board of overseers of Tufts University School of Engineering and as a trustee of Brookhaven at Lexington. She holds a B.Sc. in civil engineering from Tufts University.

Jessica Hopfield, Ph.D.

Jessica Hopfield is a former partner of McKinsey & Company in their Global Pharmaceutical practice. While at McKinsey from 1995-2009, she served clients across pharmaceutical, biotech, medical device and consumer industries with a focus on strategy , R&D management and marketing. She serves as Vice Chair of the Board Trustees of the Joslin Diabetes Center. She is the President of J Hopfield Consulting which provides strategic guidance and executive coaching to start-up technology firms seeking to commercialize intellectual property. Dr. Hopfield also held management positions at Merck Sharp and Dohme in Clinical Development, Outcomes Research, and Marketing. She earned an MBA from Harvard Graduate School of Business Administration as a Baker Scholar, a PhD in neuroscience/biochemistry from the Rockefeller University, and a BS from Yale College.